Concepedia

Sai Krishna Athaluri Divakar

SK

Statistics

Publications

6

Citations

439

H-Index

6

Active since

2014

Affiliations

Icahn School of Medicine at Mount Sinai(Current)

Albert Einstein College of Medicine

Sai Krishna Athaluri Divakar is an author at Icahn School of Medicine at Mount Sinai specializing in oncology, life sciences, and cell signaling.

ORCID

Publications per year

2014–2020

6

Publications

6

A Small Molecule RAS-Mimetic Disrupts RAS Association with Effector Proteins to Block Signaling

Sai Krishna Athaluri Divakar, Rodrigo Vasquez‐Del Carpio, Kaushik Dutta et al. · Cell · 2016 · 278 citations · Full text

, , +13

Discovery of 8-Cyclopentyl-2-[4-(4-methyl-piperazin-1-yl)-phenylamino]-7-oxo-7,8-dihydro-pyrido[2,3-<i>d</i>]pyrimidine-6-carbonitrile (<b>7x</b>) as a Potent Inhibitor of Cyclin-Dependent Kinase 4 (CDK4) and AMPK-Related Kinase 5 (ARK5)

M. V. Ramana Reddy, Balireddy Akula, Stephen C. Cosenza et al. · Journal of Medicinal Chemistry · 2014 · 71 citations · Full text

, , +15

Dual Targeting of CDK4 and ARK5 Using a Novel Kinase Inhibitor ON123300 Exerts Potent Anticancer Activity against Multiple Myeloma

Deepak Perumal, Pei-Yu Kuo, Violetta V. Leshchenko et al. · Cancer Research · 2016 · 33 citations · Full text

, , +17

Dual inhibition of CDK4/Rb and PI3K/AKT/mTOR pathways by ON123300 induces synthetic lethality in mantle cell lymphomas

Sai Krishna Athaluri Divakar, M. V. Ramana Reddy, Stephen C. Cosenza et al. · Leukemia · 2015 · 29 citations

, , +17

A Contaminant Impurity, Not Rigosertib, Is a Tubulin Binding Agent

Stacey J. Baker, Stephen C. Cosenza, Sai Krishna Athaluri Divakar et al. · Molecular Cell · 2020 · 18 citations · Full text

, , +10

1–5 of 6